BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34058148)

  • 1. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway Mucin Concentration as a Marker of Chronic Bronchitis.
    Kesimer M; Ford AA; Ceppe A; Radicioni G; Cao R; Davis CW; Doerschuk CM; Alexis NE; Anderson WH; Henderson AG; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez F; Paine R; Woodruff PG; O'Neal WK; Boucher RC
    N Engl J Med; 2017 Sep; 377(10):911-922. PubMed ID: 28877023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease.
    Kirkham S; Kolsum U; Rousseau K; Singh D; Vestbo J; Thornton DJ
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1033-9. PubMed ID: 18776153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of FEV
    Yee N; Markovic D; Buhr RG; Fortis S; Arjomandi M; Couper D; Anderson WH; Paine R; Woodruff PG; Han MK; Martinez FJ; Barr RG; Wells JM; Ortega VE; Hoffman EA; Kim V; Drummond MB; Bowler RP; Curtis JL; Cooper CB; Tashkin DP; Barjaktarevic IZ
    Chest; 2022 Apr; 161(4):949-959. PubMed ID: 34767825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
    Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
    JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
    Woodruff PG; Barr RG; Bleecker E; Christenson SA; Couper D; Curtis JL; Gouskova NA; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Lazarus SC; Martinez FJ; Paine R; Rennard S; Tashkin DP; Han MK;
    N Engl J Med; 2016 May; 374(19):1811-21. PubMed ID: 27168432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbocisteine inhibits the expression of Muc5b in COPD mouse model.
    Song Y; Wang W; Xie Y; Xiang B; Huang X; Guan W; Zheng J
    Drug Des Devel Ther; 2019; 13():3259-3268. PubMed ID: 31571828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of Secretory Mucins MUC5AC and MUC5B in Normal/Healthy Human Airways.
    Okuda K; Chen G; Subramani DB; Wolf M; Gilmore RC; Kato T; Radicioni G; Kesimer M; Chua M; Dang H; Livraghi-Butrico A; Ehre C; Doerschuk CM; Randell SH; Matsui H; Nagase T; O'Neal WK; Boucher RC
    Am J Respir Crit Care Med; 2019 Mar; 199(6):715-727. PubMed ID: 30352166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
    Henke MO; John G; Germann M; Lindemann H; Rubin BK
    Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients.
    Caramori G; Casolari P; Di Gregorio C; Saetta M; Baraldo S; Boschetto P; Ito K; Fabbri LM; Barnes PJ; Adcock IM; Cavallesco G; Chung KF; Papi A
    Histopathology; 2009 Sep; 55(3):321-31. PubMed ID: 19723147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
    Pirozzi CS; Gu T; Quibrera PM; Carretta EE; Han MK; Murray S; Cooper CB; Tashkin DP; Kleerup EC; Barjaktarevic I; Hoffman EA; Martinez CH; Christenson SA; Hansel NN; Graham Barr R; Bleecker ER; Ortega VE; Martinez FJ; Kanner RE; Paine R;
    Respir Res; 2018 Nov; 19(1):223. PubMed ID: 30454050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS.
    Martinez CH; Diaz AA; Meldrum C; Curtis JL; Cooper CB; Pirozzi C; Kanner RE; Paine R; Woodruff PG; Bleecker ER; Hansel NN; Barr RG; Marchetti N; Criner GJ; Kazerooni EA; Hoffman EA; Ross BD; Galban CJ; Cigolle CT; Martinez FJ; Han MK;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):464-472. PubMed ID: 27564413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.